Merck's CAPVAXIVE Added To Ontario's Publicly Funded Adult Immunization Program
Merck (NYSE:MRK), known as MSD outside the United States and Canada, welcomes Ontario's decision to include CAPVAXIVE® in its publicly funded adult immunization program. This addition helps expand access to
Ontario added Merck's new pneumococcal vaccine to its public health program. This means more people can get it for free, which helps Merck sell more.
Last session drawn · prints held ~15 minutes · licensed exchange data
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only. Not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.